We're committed to providing you with the very best cancer care, and your safety continues to be a top priority. With this in mind, we’ve put in place many new procedures, including a limited visitor policy. This is just one more way of ensuring your safety and that of our staff. Read more
daptive Resistance of Tumor Immunity: From a Hypothesis to Anti-PD-1/PD-L1 Therapy
Tea will be served at 1:15 pm.
This program is open to the research community.
Date & Time(s)
Memorial Sloan Kettering Cancer Center
Zuckerman Research Center
417 East 68th Street
New York, NY 10065
Lieping Chen, MD, PhD
United Technologies Chair in Cancer Research
Professor of Immunobiology, Dermatology and Medicine Director of Cancer Immunology Program, Yale Cancer Center
Yale School of Medicine
New Haven, CT